Press releases
- Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
- Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
- Nevro Enters Into Cooperation Agreement With Engaged Capital
- Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 36.68m |
Free float | 35.47m |
P/E (TTM) | -- |
Market cap | 469.16m USD |
EPS (TTM) | -2.57 USD |
Data delayed at least 15 minutes.
More ▼